Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Overman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2000 - 2003
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - Present
FL State Medical License 2021 - Present
TX State Medical License 2004 - 2028
OK State Medical License 2020 - 2027
AL State Medical License 2023 - 2026
AZ State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Clinical Trials
- Azacitidine and CAPOX in Metastatic Colorectal Cancer Start of enrollment: 2010 Aug 01
- Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma Start of enrollment: 2011 May 06
- Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF Start of enrollment: 2011 Aug 01
Publications & Presentations
PubMed
- Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms.Ashlee N Seldomridge, Michael G White, Christopher Scally, Richard E Royal, Mark Routbort
Annals of Surgical Oncology. 2026-03-01 - ASO Visual Abstract: Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms.Ashlee N Seldomridge, Michael G White, Christopher Scally, Richard E Royal, Mark Routbort
Annals of Surgical Oncology. 2026-03-01 - Impact of RAS/BRAFV600E Mutations on the Tumor Immune Microenvironment in Mismatch Repair-Deficient/Microsatellite Instability Colorectal Cancers.Mohamed E Salem, Alberto Puccini, Elizabeth Mauer, Thierry André, Thomas J George
Clinical Cancer Research. 2026-01-16
Journal Articles
- Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients with CancerMichael J Overman, Adi Diab, Patrick Hwu, JAMA Network Open
- Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-ChallengeB Kee, N Garg, M J Overman, V K Morris, B Johnson, J Wu, J H Strickler, S Kopetz, X Liu, D S Hong, Annals of Oncology
Lectures
- How to Approach Biomarker Testing for Colorectal Cancer in 2019ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
- A priori filtering of post-operative (post-op) circulating tumor DNA (ctDNA) to predict recurrence in post-metastasectomy colorectal cancer patients (CRC pts) without ...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (pa...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Other
- Epidemiology, clinical features, and types of small bowel neoplasmsOverman MJ, Cusack JC
http://www.uptodate.com/contents/epidemiology-clinical-features-and-types-of-small-bowel-neoplasms
UpToDate, Wolters Kluwer Health - 2012-07-27 - Diagnosis and staging of small bowel neoplasmsOverman MJ, Cusack JC
http://www.uptodate.com/contents/diagnosis-and-staging-of-small-bowel-neoplasms
UpToDate, Wolters Kluwer Health - 2013-01-16 - Treatment of small bowel neoplasmsOverman MJ, Cusack JC
http://www.uptodate.com/contents/treatment-of-small-bowel-neoplasms
UpToDate, Wolters Kluwer Health - 2012-11-01
Authored Content
- Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients with CancerJuly 2020
Press Mentions
PD-1 Inhibitor Helps Patients with dMMR Tumors Avoid SurgeryApril 28th, 2025- A New Medicine Spares Cancer Patients from Difficult Surgeries and TherapiesApril 27th, 2025
- AACR: Researchers Share Promising Results from MD Anderson Clinical TrialsApril 25th, 2025
Grant Support
- A technological approach for performance status assessment in advanced cancer patientsUNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
